Chairman & CEO of Agenus Inc. (NASDAQ:AGEN) Garo H. Armen bought 2,150,976 shares of the company on 08/16/2011 at an average price of $0.51. The total transaction amount is $1,096,998. Agenus Inc., formerly known as Antigenics Inc., is engaged in the discovery, development and commercialization of immunotherapeutics for the treatment of life-threatening and chronic medical conditions. Agenus Inc. has a market cap of $60.1 million; its shares were traded at around $0.5501 with and P/S ratio of 17.9.
Garo Armen has held officer positions in the company since January of 1994. From 2002 through 2004, he was chairman of the board of directors for Elan Corp., a pharmaceutical company. He is also the founder and president of the Children of Armenia fund, which was established in 2000.
Agenus Inc. recently reported its results for the quarter and six months ended June 30, 2011. The company reported a net loss attributable to common stockholders of $6.0 million, or $0.05 per share, basic and diluted, for the second quarter of 2011, compared with a net loss attributable to common stockholders in the second quarter of 2010 of $5.2 million, or $0.05 per share, basic and diluted.
Robert Bruce owns 1,401,099 shares as of 06/30/2011, which accounts for 0.5309% of the $206 million portfolio of Bruce & Co.
Agenus Inc. has a predictability rating of 1 star.
- CEO Buys, CFO Buys: Stocks that are bought by their CEO/CFOs.
- Insider Cluster Buys: Stocks that multiple company officers and directors have bought.
- Double Buys:: Companies that both Gurus and Insiders are buying
- Triple Buys: Companies that both Gurus and Insiders are buying, and Company is buying back.